FDA Announces New Recommendations for Acceptable Limits of Nitrosamine in Drugs
Guidance comes after a number of massive drug recalls issued in recent years due to nitrosamine contamination, which could increase cancer risks.
Tag Archives: Chantix
-
-
Drugs Advertised on TV Often Have Low Therapeutic Value, Study Finds
Drug companies spend billions of dollars on television commercials for drugs that are more expensive and less effective than other treatments, according to the findings
-
Chantix Recall Lawsuits Over Cancer Risk Consolidated in Southern District of New York
The Chantix lawsuits all involve similar claims stemming from the discovery of cancer-causing nitrosamine-based impurities in 2021.
-
Nitrosamines Problems Are More Widespread in Drugs Than FDA Anticipated: Report
The EU and Canada have set daily acceptable limits for all nitrosamines, but the FDA has not. During a meeting this week the U.S. regulators met to discuss how to bets address the problem with nitrosames in drugs.
-
Consolidation of Chantix Recall Lawsuits to Be Considered By JPML in December
The MDL Panel will hear oral arguments on whether all federal Chantix recall lawsuits should be centralized before one federal judge.
-
MDL Sought for Chantix Lawsuits Over Cancer-Causing Contaminants
Motion seeks to consolidate and centralize all Chantix class action lawsuits over cancerous chemicals that contaminated the stop smoking drug
-
Class Action Lawsuit Filed Over Presence of Toxic Chemicals in Chantix
Lawsuits claim the presence of nitrosamines make Chantix an adulterated drug never approved by the FDA.
-
Class Action Lawsuit Over Chantix Nitrosamine Impurities Filed Against Pfizer
Cancer causing chemical impurity in Chantix, identified as N-nitroso-varenicline, makes stop-smoking drug an illegally manufactured and distributed medication.
-
Lupin Irebesartan Recall Issued Over Cancer Causing N-nitrosoirbesartan Contamination
-
Generic Chantix Launched Following Recall of Name Brand Drug Due To Toxic Contaminant
